Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-blind, Placebo-controlled, Single Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of CNTX-4975-05 in Subjects With Chronic, Moderate-to-severe Osteoarthritis Knee Pain

Next Previous
X
Search
Trial Profile

A Randomized, Double-blind, Placebo-controlled, Single Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of CNTX-4975-05 in Subjects With Chronic, Moderate-to-severe Osteoarthritis Knee Pain

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jan 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Capsaicin (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Acronyms VICTORY-1
  • Sponsors Centrexion Therapeutics

    • Most Recent Events

    • 15 Nov 2023 Results of an analysis from combined data set from two studies (CNTX4975i-OA301 and CNTX4975i-OA304) reporting primary time point at week 12 with the numeric pain rating scale (Primary OA-301) between NPRS and WOMAC-A (Primary OA-304) presented at the ACR Convergence 2023
    • 15 Nov 2023 Primary endpoint has not been met. (Change From Baseline in Average Weekly Pain With Walking (NPRS 0-10) in the Index Knee), as per Results presented at the ACR Convergence 2023
    • 15 Nov 2023 Results presented at the ACR Convergence 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top